These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30269890)

  • 21. Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.
    Teixeira A; Arrigo M; Vergaro G; Cohen-Solal A; Mebazaa A
    Arch Gerontol Geriatr; 2017; 68():33-38. PubMed ID: 27611369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-3, a prognostic marker--and a therapeutic target?
    Pereira AR; Menezes Falcão L
    Rev Port Cardiol; 2015 Mar; 34(3):201-8. PubMed ID: 25746675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic Peptides and Analytical Barriers.
    Vasile VC; Jaffe AS
    Clin Chem; 2017 Jan; 63(1):50-58. PubMed ID: 28062611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic Peptides and the Management of Heart Failure.
    Kern T; Kedan I; Kimchi A
    Rev Cardiovasc Med; 2015; 16(2):95-104. PubMed ID: 26198556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natriuretic Peptides in Cardiac Anesthesia and Intensive Care.
    Krichevskiy LA; Kozlov IA
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1407-1419. PubMed ID: 30228053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of natriuretic peptides.
    Doust JA
    Arch Intern Med; 2005 May; 165(10):1199. PubMed ID: 15931718
    [No Abstract]   [Full Text] [Related]  

  • 28. Natriuretic peptides as biomarkers in heart failure.
    Januzzi JL
    J Investig Med; 2013 Aug; 61(6):950-5. PubMed ID: 23661103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients].
    Di Lenarda A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.
    Baba M; Yoshida K; Ieda M
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
    Gruson D; Ahn SA; Rousseau MF
    Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study.
    Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E
    Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypervolemic and optivolemic natriuretic peptides in acute heart failure.
    Xue Y; Taub PR; Fard A; Maisel AS
    Contrib Nephrol; 2011; 171():74-79. PubMed ID: 21625093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice].
    Kovács LG; Nyolczas N; Habon T; Sepp R; Piroth Z; Hajas Á; Boncz I; Tomcsányi J; Kappelmayer J; Merkely B
    Orv Hetil; 2015 Aug; 156(31):1235-45. PubMed ID: 26211747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.
    Wright GA; Struthers AD
    Heart; 2006 Feb; 92(2):149-51. PubMed ID: 16216866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic peptide testing in clinical medicine.
    Rehman SU; Januzzi JL
    Cardiol Rev; 2008; 16(5):240-9. PubMed ID: 18708825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis.
    Khan MS; Siddiqi TJ; Usman MS; Sreenivasan J; Fugar S; Riaz H; Murad MH; Mookadam F; Figueredo VM
    Int J Cardiol; 2018 Jul; 263():80-87. PubMed ID: 29685696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.